Abstract
The role of nitric oxide synthase type-2 (NOS2)-derived nitric oxide (NO) in the pathogenesis of mouse hepatitis virus (MHV)-induced central nervous system disease was examined. Infection of NOS2 knockout (−/−) and NOS2+/+ mice with MHV resulted in similar kinetics of viral clearance from the brain and comparable levels of demyelination. MHV-infected NOS2−/− mice displayed a marked decrease in mortality as compared to infected NOS2+/+ mice that correlated with a significant decrease (P ≤ 0.001) in the number of apoptotic cells (determined by TUNEL staining) present in the brain. Confocal microscopy revealed that the majority of cells (>70%) undergoing apoptosis were neurons. These studies indicate that NOS2-generated NO contributes to apoptosis of neurons but not demyelination following MHV infection.
Article PDF
References
Adams LB, Hibbs JB Jr, Taintor RR, Krahenbuhl JL (1990). Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 144: 2725–2729.
Adler H, Beland JL, Del-Pan NC, Kobzik L, Brewer JP, Martin TR, Rimm I (1997). Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS-2). J Exp Med 185: 1533–1540.
Akaike T, Weihe E, Schaefer M, Fu ZF, Zheng YM, Vogel W, Schmidt H, Koprowski H, Dietzschold B (1995). Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J NeuroVirol 1: 118–125.
Allione A, Bernabei P, Bosticardo M, Ariotti S, Forni G, Novelli F (1999). Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis. J Immunol 163: 4182–4191.
Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod JJ, Mazzei G, Maundrell K, Gambale F, Sadoul R, Martinou JC (1997). Inhibition of Bax channel-forming activity by Bcl-2. Science 277: 370–372.
Campbell IL (1996). Exacerbation of lymphocytic choriomeningitis in mice treated with the inducible nitric oxide synthase inhibitor aminoguanidine. J Neuroimmunol 71: 31–36.
Dalziel RG, Lampert PW, Talbot PJ, Buchmeier MJ (1986). Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol 59: 463–471.
Dawson TM, Zhang J, Dawson VL, Snyder SH (1994). Nitric oxide: cellular regulation and neuronal injury. Prog Brain Res 103: 365–369.
Dimmeier S, Zeiher AM (1997). Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1: 275–281.
Grzybicki DM, Kwack KB, Perlman S, Murphy SP (1997). Nitric oxide synthase type II expression by different cell types in MHV-JHM encephalitis suggests distinct roles for nitric oxide in acute versus persistent virus infection. J Neuroimmunol 73: 15–27.
Hirona N, Murakami T, Fujiwara K, Matsumoto M (1978). Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. Jpn J Exp Med 48: 71–75.
Houtman JJ, Fleming JO (1996). Pathogenesis of mouse hepatitis virus-induced demyelination. J NeuroVirol 2: 361–376.
Karupiah G, Xie QW, Buller RML, Nathan CF, Duarte C, MacMicking JD (1993). Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261: 1445–1448.
Keane RW, Srinivasan A, Foster LM, Testa MP, Ord T, Nonner D, Wang HG, Reed JC, Bredesen DE, Kayalar C (1997). Activation of CPP32 during apoptosis of neurons and astrocytes. J Neurosci Res 48: 168–180.
Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B (1993). In vivo expression of inducible nitric oxide synthase in experimentally induced neurological disease. Proc Natl Acad Sci USA 90: 3024–3027.
Lane TE, Buchmeier MJ (1997a). Murine coronavirus infection: a paradigm for virus-induced demyelination disease. Trends Microbiol 5: 9–15.
Lane TE, Fox HS, Buchmeier MJ (1999). Inhibition of nitric oxide synthase-2 reduces the severity of mouse hepatitis virus-induced demyelination: implications for NOS2/NO regulation of chemokine expression and inflammation. J NeuroVirol 5: 48–54.
Lane TE, Liu MT, Chen BP, Asensio AC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ (2000). A central role for CD4+ T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 74: 1420–1424.
Lane TE, Paoletti AD, Buchmeier MJ (1997b). Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J Virol 71: 2202–2210.
Lane TE, Wu-Hsieh BA, Howard EH (1994). Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates. Infect Immun 62: 1940–1945.
Liu MT, Chen BC, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE (2000). The T cell chemoattractant IFN-inducible Protein 10 (IP-10) is essential in host defense against viral-induced neurologic disease. J Immunol 165: 2327–2330.
MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF (1997a). Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94: 5243–5248.
MacMicking JD, Xie QW, Nathan CF (1997b). Nitric oxide and macrophage function. Annu Rev Immunol 15: 323–350.
Mebmer UK, Reed JC, Brune B (1996). Bcl-2 protects macrophages from nitric oxide-induced apoptosis. JRiol Chem 271: 20192–20197.
Melkova Z, Lee SB, Rodriguez D, Esteban M (1997). Bcl-2 prevents nitric oxide-mediated apoptosis and poly (ADP-ribose) polymerase cleavage. FERS Lett 403: 273–278.
Meyding-Lamade U, Haas J, Lamade W, Stingele K, Kehm R, Fath A, Heinrich K, Storch Hagenlocher B, Wildermann B (1998). Herpes simplex virus encephalitis: long-term comparative study of viral load and the expression of immunologic nitric oxide synthase in mouse brain tissue. Neurosci Lett 244: 9–12.
Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR (1992). DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 89: 3030–3034.
Oleszak EL, Katsetos CD, Kuzmak J, Varadhachary A (1997). Inducible nitric oxide synthase in Theiler’s murine encephalomyelitis virus infection. J Virol 71: 3228–3235.
Raber J, Toggas SM, Lee S, Bloom FE, Epstein CJ, Mucke L (1996). Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase. Virology 226: 362–373.
Rose JW, Hill Y, Kurtz CI, Tsunoda I, Fujinami RS, Cross AJ (1998). Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler’s virus infection. J Neuroimmunol 81: 82–89.
Stuehr DJ, Nathan CF (1989). Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543–1555.
Sun N, Grzybicki D, Castro RF, Murphy S, Perlman S (1995). Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213: 482–493.
Tamatani M, Ogawa S, Niitsu Y, Tohyama M (1998). Involvement of Bcl-2 family and caspase-3-like protease in NO-mediated neuronal apoptosis. J Neurochem 71: 1588–1596.
Wu GF, Pewe L, Perlman S (2000). Coronavirus-induced demyelination occurs in the absence of inducible nitric oxide synthase. J Virol 74: 7683–7686.
Yuan JY, Yankner BA (2000). Apoptosis in the nervous system. Nature 407: 802–809.
Zaragoza C, Ocampo CJ, Saura M, Bao C, Leppo M, Lafond-Walker A, Thiemann DR, Hruban R, Lowenstein CJ (1999). Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. J Immunol 163: 5497–5504.
Zhang J, Dawson VL, Dawson TM, Snyder SH (1994). Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687–689.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, B.P., Lane, T.E. Lack of nitric oxide synthase type 2 (NOS2) results in reduced neuronal apoptosis and mortality following mouse hepatitis virus infection of the central nervous system. Journal of NeuroVirology 8, 58–63 (2002). https://doi.org/10.1080/135502802317247820
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/135502802317247820